Library
A randomized controlled proof-of-concept trial of digoxin and furosemide in adults with cutaneous warts.
18 March 2019. doid: 10.1111/bjd.17583
Rijsbergen M, Niemeyer-van der Kolk T, Hogendoorn G, Kouwenhoven S, Lemoine C, Klaassen ES, de Koning M, Beck S, Bouwes Bavinck JN, Feiss G, Burggraaf J, Rissmann R
View publicationTopical ionic contraviral therapy (ICVT) with digoxin and furosemide inhibits the potassium influx on which DNA viruses rely for replication. Therefore, ICVT was hypothesized to be a potential novel treatment for cutaneous warts.
Advancing the boundaries of clinical drug development
Wondering how we can help you? Reach out to us.
